Angiosoma, Inc. (SOAN) SEC Filing 10-Q Quarterly report for the period ending Tuesday, March 31, 2020

Angiosoma, Inc.

CIK: 1502152 Ticker: SOAN
Cover - shares
6 Months Ended
Mar. 31, 2020
May 04, 2020
Cover [Abstract]  
Entity Registrant NameAngioSoma, Inc. 
Entity Central Index Key0001502152 
Document Type10-Q 
Document Period End DateMar. 31, 2020 
Amendment Flagfalse 
Current Fiscal Year End Date--09-30 
Entity File Number333-170315 
Entity Incorporation, State or Country CodeWY 
Entity Current Reporting StatusYes 
Entity Interactive Data CurrentYes 
Entity Filer CategoryNon-accelerated Filer 
Entity Small Businesstrue 
Entity Emerging Growth Companyfalse 
Entity Shell Companyfalse 
Entity Common Stock, Shares Outstanding 319,439,508
Document Fiscal Period FocusQ2 
Document Fiscal Year Focus2020 

View differences made from one quarter to another to evaluate Angiosoma, Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Angiosoma, Inc..


Assess how Angiosoma, Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Angiosoma, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2020 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


SEC Filing Tools

Material Contracts, Statements, Certifications & more

Angiosoma, Inc. provided additional information to their SEC Filing as exhibits

Ticker: SOAN
CIK: 1502152
Form Type: 10-Q Quarterly Report
Accession Number: 0001161697-20-000187
Submitted to the SEC: Tue May 05 2020 2:57:22 PM EST
Accepted by the SEC: Tue May 05 2020
Period: Tuesday, March 31, 2020
Industry: Pharmaceutical Preparations

External Resources:
Stock Quote
Social Media

Bookmark the Permalink: